← Back to headlines
Revolution Medicines Achieves Pancreatic Cancer Breakthrough Amid $47B Valuation
Biotech firm Revolution Medicines has made historic strides in pancreatic cancer treatment, though analysts note its current $47 billion market cap already prices in this success.
28 Aug, 20:54 — 28 Aug, 20:54
Sources
Showing 1 of 1 sources
